In the present study, NUDT3's and myogenin have demonstrated efficacy as diagnostic methods for sarcopenia. The EX-CrM combination showed a notable improvement in the lipid profile and antioxidant and anti-inflammatory effects. This evidence concerns the gene NUDT3 and sarcopenia.